Jefferies Group’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-241
Closed -$2 1494
2020
Q2
$2 Buy
+241
New +$1.76K ﹤0.01% 1216
2020
Q1
Sell
-45,680
Closed -$236K 2498
2019
Q4
$236K Sell
45,680
-8,571
-16% -$55K ﹤0.01% 2180
2019
Q3
$315K Buy
+54,251
New +$243K ﹤0.01% 2156
2019
Q2
Sell
-27,078
Closed -$111K 2780
2019
Q1
$111K Sell
27,078
-22,926
-46% -$145K ﹤0.01% 2094
2018
Q4
$317K Buy
50,004
+31,455
+170% +$327K ﹤0.01% 1636
2018
Q3
$306K Sell
18,549
-7,619
-29% -$129K ﹤0.01% 1866
2018
Q2
$437K Buy
26,168
+26
+0.1% +$421 ﹤0.01% 1664
2018
Q1
$407K Sell
26,142
-14,039
-35% -$250K ﹤0.01% 1613
2017
Q4
$759K Buy
40,181
+17,769
+79% +$394K ﹤0.01% 1527
2017
Q3
$654K Buy
+22,412
New +$662K ﹤0.01% 1497

Other funds holding ACH

Jefferies Group's ACH Position: Q3 2020 in Review

Jefferies Group sold out of Accendra Health (ACH) in Q3 2020, closing a stake of 241 shares — an estimated $2 sold.

Jefferies Group first reported a position in ACH in Q3 2017 and held it in 10 quarters. The position peaked at $759K in Q4 2017. 204 funds tracked by Wall St. Rank hold ACH as of Q3 2020.

  • Jefferies Group reported no remaining Accendra Health position as of Q3 2020 after selling out during the quarter.
  • Jefferies Group sold 241 Accendra Health shares in Q3 2020, an estimated $2.
  • Jefferies Group first reported a position in Accendra Health in Q3 2017 and held it in 10 quarters.
  • Jefferies Group's Accendra Health position peaked at $759K in Q4 2017.
  • 204 funds tracked by Wall St. Rank held Accendra Health as of Q3 2020.

Based on Jefferies Group's 13F filing for Q3 2020, filed 13 Nov 2020.